OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases
Chirag Patel, Sonal Pande, Vrunda Sagathia, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 837-837
Open Access | Times Cited: 12

Showing 12 citing articles:

Future Directions in Diabetic Retinopathy Treatment: Stem Cell Therapy, Nanotechnology, and PPARα Modulation
Maria Kąpa, Iga Koryciarz, Natalia Kustosik, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 683-683
Open Access | Times Cited: 2

Lipid-based nanoparticles: innovations in ocular drug delivery
Mirza Salman Baig, Shweta Kulkarni Karade, Anas Ahmad, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 8

Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball
Rongyue Xue, Hao Wu, Siyu Li, et al.
Materials Today Bio (2024) Vol. 27, pp. 101126-101126
Open Access | Times Cited: 7

New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases
Cornelis J.F. Van Noorden, Bahar Yetkin-Arik, Paola Serrano Martinez, et al.
Journal of Histochemistry & Cytochemistry (2024) Vol. 72, Iss. 5, pp. 329-352
Open Access | Times Cited: 6

Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives
Jiayan Huang, Yan Zhao, Yafang Song, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 651-651
Open Access | Times Cited: 6

Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases
Georgia Savvidou, Ellas Spyratou, Maria-Eleni Zachou, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 6-6
Open Access

Pullulan as a sustained release carrier for ocular drug delivery: a review
Aarushi Kaith, Unnati Garg, Neha Jain, et al.
International Journal of Biological Macromolecules (2025), pp. 143146-143146
Closed Access

Review: Neuroprotective Nanocarriers in Glaucoma
Kun Pei, Maria Georgi, Daniel Hill, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1190-1190
Open Access | Times Cited: 2

An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye
Sai H. S. Boddu, Devarshi Acharya, Vivek Hala, et al.
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35470-35498
Open Access | Times Cited: 5

Inhibition of Uridine 5′-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies
Sonal Pande, Chirag Patel, Tejas M. Dhameliya, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 1

Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Diabetic Retinopathy: An Attractive but Elusive Choice for Drug Development
Etelka Pöstyéni, R. Gábriel, Andrea Kovács-Valasek
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1320-1320
Open Access

Page 1

Scroll to top